Dr. Andrea Bezjak is a Professor in the Departments of Radiation Oncology and Health Policy, Management and Evaluation at the University of Toronto, and staff radiation oncologist at Princess Margaret Hospital.
Her clinical expertise is in the management of lung cancers and palliative radiotherapy. In Aug 2003, she assumed leadership of the Radiation Medicine Program (RMP) Lung Group, and has created a multi-professional team that has embarked on a program of high precision radiotherapy in lung cancer, utilizing the cutting-edge technology now available within RMP including 4 D-CT for treatment planning, PET-CT simulator for target definition and cone beam CT for image verification.
She is the local PI of the RTOG phase I/II study of stereotactic RT for T1-T3NO non-small cell lung cancers in medically inoperable patients. She is also collaborating with Dr. Richard Hill and others in assessing the effect of radiotherapy on normal tissues, particularly lung.
Her clinical expertise is in the management of lung cancers and palliative radiotherapy. In Aug 2003, she assumed leadership of the Radiation Medicine Program (RMP) Lung Group, and has created a multi-professional team that has embarked on a program of high precision radiotherapy in lung cancer, utilizing the cutting-edge technology now available within RMP including 4 D-CT for treatment planning, PET-CT simulator for target definition and cone beam CT for image verification.
She is the local PI of the RTOG phase I/II study of stereotactic RT for T1-T3NO non-small cell lung cancers in medically inoperable patients. She is also collaborating with Dr. Richard Hill and others in assessing the effect of radiotherapy on normal tissues, particularly lung.